Explore evidence

54 %HIV-specific CD8(+) T-cell responses were detected in 25 of 46 participants (54%) before HIV acquisition.

KenyaVIH/sidapublished 2010AIDS (London, England)europe_pmcdocument of 2 observationsDOI 10.1097/qad.0b013e3283391d40

9.1 %Viral load monitoring reduced vertical transmission by 9.1–14.3% in known positive women in Kenya.

KenyaVIH/sidapublished 2025AIDS (London, England)PubMeddocument of 6 observations

19,000 casesIn 2020, Kenya had 19,000 new HIV infections among women aged 15+ years.

KenyaVIH/sidaobserved 2020published 2023Journal of the International AIDS SocietyPubMeddocument of 10 observations

15.3 percentage_pointsStandardized patient actor training resulted in an adjusted mean difference of 15.3 percentage points in quality score for preexposure prophylaxis (PrEP) care between intervention and control sites.

KenyaVIH/sidapublished 2024AIDS (London, England)PubMeddocument of 9 observations

4 log_10_copies_per_mLThere were no viral load differences between men who were circumcised and uncircumcised at the time of HIV infection (means 4.00 and 4.03 log 10 copies/mL respectively, p = .88) in any analysis.

KenyaVIH/sidapublished 2018BMC infectious diseaseseurope_pmcdocument of 2 observations

9.41 %Thirteen (9.41%) infants had a positive PCR test during the 12-month study period.

KenyaVIH/sidapublished 2023PLoS ONEOpenAlexdocument of 5 observations

0.81 adjusted_odds_ratioDMPA exposure did not increase detection of plasma HIV-1 RNA compared with visits with no hormonal contraception exposure (adjusted odds ratio: 0.81, 95% confidence interval: 0.47 to 1.39).

KenyaVIH/sidapublished 2014Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 2 observations

6.6 aHRAmong patients switching to dolutegravir-containing regimens, those with a preswitch viral load ≥1000 copies/mL had an adjusted hazard ratio of 6.60 for incident viral load ≥1000 copies/mL compared to those with preswitch viral load <200 copies/mL.

KenyaVIH/sidapublished 2022Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

49.4 %Among 11,239 HIV-positive persons who named ≥1 contact in the SEARCH Study in rural Kenya and Uganda between 2013 and 2014, 49.4% had viral nonsuppression.

KenyaVIH/sidaobserved 2013 and 2014published 2021Epidemiology (Cambridge, Mass.)PubMeddocument of 3 observations

59 %59% of participants cited desire to receive education about HIV as a motivating factor for participation.

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 7 observations

54 %Of the postpartum Kenyan women with HIV surveyed, 54% reported successful completion of the PMTCT continuum of care.

KenyaVIH/sidaobserved 2017published 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 4 observations

10 %Among male participants excluding those reporting sexual debut before baseline, 10% (20 of 202) in the control group versus 8% (16 of 201) in the intervention group reported a high-risk sexual debut.

KenyaVIH/sidapublished 2026The Lancet. Child & adolescent healthPubMeddocument of 3 observations

82 %Out of 1,444 call attempts, 82% successfully reached youth living with HIV (YLH).

KenyaVIH/sidaobserved June 2020 to January 2021published 2025BMC health services researchPubMeddocument of 2 observations

1.73 hazard_ratioUse of depot medroxyprogesterone acetate was associated with an adjusted hazard ratio of 1.73 for HIV-1 acquisition.

KenyaVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 6 observationsDOI 10.1097/qad.0b013e328270388a

37.3 %The prevalence of condom-only contraception among HIV-positive female sex workers in Mombasa, Kenya was 37.3%.

KenyaVIH/sidapublished 2019PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0218291

HIV drug resistance threatens progress achieved in response to the HIV epidemic.

KenyaVIH/sidapublished 2020F1000ResearchPubMeddocument of 3 observations

0.73 annual_incidence_rate_ratioFor every successive year since 2009, the risk of HIV infection declined with an annual incidence rate ratio of 0.73.

KenyaVIH/sidaobserved 2009published 2025AIDS and behaviorPubMeddocument of 5 observations

251 per_100000The HIV/AIDS mortality rate was 251 per 100,000 population.

KenyaVIH/sidaobserved 2019published 2022PloS onePubMeddocument of 8 observations

12.5 %Each additional year of ART use reduced the likelihood of detection of HR-HPV by 10-15% among Kenyan women living with HIV.

Kenyainfection à HPV · VIH/sidapublished 2021International journal of STD & AIDSPubMeddocument of 5 observations

86 %Among 71 treatment-naive men who have sex with men with HIV in the HIV Prevention Trials Network 075 study, 86% sought HIV care following a positive diagnosis.

KenyaVIH/sidaobserved 2015-2017published 2025AIDS patient care and STDsPubMeddocument of 3 observations

3 monthsThe median time to death was 3 months among patients initiated on antiretroviral therapy in central Kenya.

KenyaVIH/sidapublished 2022BMC infectious diseasesPubMeddocument of 10 observations

100 %In Kenya, point-of-care (POC) early infant diagnosis increased the percentage of HIV-infected infants initiated on treatment to 100%.

KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 13 observations

32.8 %The magnitude of any type of post-TB lung disease was 32.8% among HIV-positive individuals in low- and middle-income countries.

Kenyapost-TB lung disease · VIH/sidapublished 2022PLOS global public healtheurope_pmcdocument of 11 observationsDOI 10.1371/journal.pgph.0000805

1.32 aHRAmong sexual contacts of HIV-positive index clients in Siaya County, Kenya, those aged 18–24 years had an adjusted hazard ratio of 1.32 for HIV testing compared to those aged 35–44 years.

KenyaVIH/sidaobserved June 2017-August 2018published 2020PloS onePubMeddocument of 8 observations

8 %Only 316 (8%) of the unsuppressed adolescents and young adults living with HIV in Kenya had a repeat viral load test within 3 months.

KenyaVIH/sidaobserved April 2017 to May 2019published 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 7 observations